News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
140 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
What You Need to Know About Apostle
Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
December 4, 2017
·
5 min read
·
Mark Terry
Business
What You Need to Know About BlueRock Therapeutics
BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.
December 4, 2017
·
8 min read
·
Mark Terry
Deals
Exactech Gets Sweetened $737M Cash Deal From TPG Capital
The revised offer of $49.25 per share represents an increase of 17.3 percent to the previously announced $42 per share, the company said.
December 4, 2017
·
1 min read
Genetown
ProMIS Neurosciences Announces Trading on OTCQB Venture Market
ProMIS Neurosciences common shares will continue to trade on the Toronto Stock Exchange.
December 4, 2017
·
3 min read
BioMidwest
Life Science’s Fastest Growing Job Right Now
A look at the one position that stands out for its role in the biopharma industry.
December 4, 2017
·
4 min read
·
Mark Terry
Bio NC
Top 20 Life Science Startups to Watch in 2018
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
December 4, 2017
·
9 min read
·
Mark Terry
Policy
CareFusion Issues Warning to Customers Over Alaris Syringe Pump Alarm
The company warns that pumps made before 2008 may display an error message that could stop the pump from working.
December 4, 2017
·
1 min read
Drug Development
BioLineRx Reports Overall Survival Results From Long-Term Follow-Up of Phase IIa Trial in r/r AML
The results demonstrate that the combination of BL-8040 with HiDAC in this difficult-to-treat patient population significantly improved overall survival, compared with historical data of HiDAC monotherapy.
December 4, 2017
·
6 min read
Business
What You Need to Know About CBT Pharmaceuticals
Based in Santa Clara, California, CBT Pharma was spun out of Crown Bioscience with four development-stage assets in the oncology space.
December 4, 2017
·
4 min read
·
Mark Terry
Drug Development
Ra Pharma Crashed as Certain Patients Failed to Tolerate Switch From Alexion’s Soliris
The patients who were transfusion dependent and switched from Soliris were forced to switch back to the Alexion drug.
December 4, 2017
·
3 min read
·
Alex Keown
1 of 14
Next